Journal
ONCOGENE
Volume 29, Issue 34, Pages 4787-4799Publisher
NATURE PUBLISHING GROUP
DOI: 10.1038/onc.2010.232
Keywords
decatenation; G(2) checkpoint; topoisomerase II alpha; topoisomerase II beta; chromosomal instability
Funding
- NIH-NCI Ruth L. Kirschstein National Research Service [1F32CA134155-01]
- PHS [CA81343, P30-ES10126]
Ask authors/readers for more resources
Topoisomerase II alpha (topoII alpha) is an essential mammalian enzyme that topologically modifies DNA and is required for chromosome segregation during mitosis. Previous research suggests that inhibition of topoII decatenatory activity triggers a G(2) checkpoint response, which delays mitotic entry because of insufficient decatenation of daughter chromatids. Here we examine the effects of both topoII alpha and topoII beta on decatenatory activity in cell extracts, DNA damage and decatenation G(2) checkpoint function, and the frequencies of p16(INK4A) allele loss and gain. In diploid human fibroblast lines, depletion of topoII alpha by small-interfering RNA was associated with severely reduced decatenatory activity, delayed progression from G(2) into mitosis and insensitivity to G(2) arrest induced by the topoII catalytic inhibitor ICRF-193. Furthermore, interphase nuclei of topoII alpha-depleted cells showed increased frequencies of losses and gains of the tumor suppressor genetic locus p16(INK4A). This study shows that the topoII alpha protein is required for decatenation G(2) checkpoint function, and inactivation of decatenation and the decatenation G(2) checkpoint leads to abnormal chromosome segregation and genomic instability. Oncogene (2010) 29, 4787-4799; doi:10.1038/onc.2010.232; published online 21 June 2010
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available